Brief: Index Pharmaceuticals Holding Expects To Have Recruited 30% Of Patients In Induction Study 1 in Q3
Aug 23 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* LOOKING FORWARD TO Q3, WE ARE EXPECTING TO HAVE RECRUITED
30% OF
PATIENTS IN INDUCTION STUDY 1
Source text for Eikon: ID:nWkr3YmvRD
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen